118 related articles for article (PubMed ID: 31732921)
1. Regulation of B cell homeostasis by Ptpn22 contributes to type 1 diabetes in NOD mice.
Shi X; Shao F; Li Z; Kang L; Liu J; Kissler S; Zhou Z; Jia L; Zheng P
Endocrine; 2020 Mar; 67(3):535-543. PubMed ID: 31732921
[TBL] [Abstract][Full Text] [Related]
2. Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic Mice.
Fraser HI; Howlett S; Clark J; Rainbow DB; Stanford SM; Wu DJ; Hsieh YW; Maine CJ; Christensen M; Kuchroo V; Sherman LA; Podolin PL; Todd JA; Steward CA; Peterson LB; Bottini N; Wicker LS
J Immunol; 2015 Nov; 195(10):4841-52. PubMed ID: 26438525
[TBL] [Abstract][Full Text] [Related]
3. PTPN22 silencing in the NOD model indicates the type 1 diabetes-associated allele is not a loss-of-function variant.
Zheng P; Kissler S
Diabetes; 2013 Mar; 62(3):896-904. PubMed ID: 23193190
[TBL] [Abstract][Full Text] [Related]
4. PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner.
Fousteri G; Jofra T; Di Fonte R; Kuka M; Iannacone M; Battaglia M
Clin Immunol; 2015 Feb; 156(2):98-108. PubMed ID: 25513733
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9-Mediated Modification of the NOD Mouse Genome With Ptpn22R619W Mutation Increases Autoimmune Diabetes.
Lin X; Pelletier S; Gingras S; Rigaud S; Maine CJ; Marquardt K; Dai YD; Sauer K; Rodriguez AR; Martin G; Kupriyanov S; Jiang L; Yu L; Green DR; Sherman LA
Diabetes; 2016 Aug; 65(8):2134-8. PubMed ID: 27207523
[TBL] [Abstract][Full Text] [Related]
6. Analysis of PTPN22 C1858T gene polymorphism in cases with type 1 diabetes of Azerbaijan, Northwest Iran.
Almasi S; Aliparasti MR; Yazdchi-Marandi L; Aliasgarzadeh A; Sioofy-Khojine A; Mesri A; Zamani F
Cell Immunol; 2014; 292(1-2):14-8. PubMed ID: 25243643
[TBL] [Abstract][Full Text] [Related]
7. Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T PTPN22 allelic variant: implications in the disease pathogenesis.
Gianchecchi E; Crinò A; Giorda E; Luciano R; Perri V; Russo AL; Cappa M; Rosado MM; Fierabracci A
PLoS One; 2014; 9(10):e110755. PubMed ID: 25333705
[TBL] [Abstract][Full Text] [Related]
8. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes.
Dultz G; Matheis N; Dittmar M; Röhrig B; Bender K; Kahaly GJ
Thyroid; 2009 Feb; 19(2):143-8. PubMed ID: 19090780
[TBL] [Abstract][Full Text] [Related]
9. The putative role of the C1858T polymorphism of protein tyrosine phosphatase PTPN22 gene in autoimmunity.
Gianchecchi E; Palombi M; Fierabracci A
Autoimmun Rev; 2013 May; 12(7):717-25. PubMed ID: 23261816
[TBL] [Abstract][Full Text] [Related]
10. A functional polymorphism of Ptpn22 is associated with type 1 diabetes in the BioBreeding rat.
Sarmiento J; Wallis RH; Ning T; Marandi L; Chao G; Veillette A; Lernmark Å; Paterson AD; Poussier P
J Immunol; 2015 Jan; 194(2):615-29. PubMed ID: 25505293
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase non-receptor type 22 gene variants at position 1858 are associated with type 1 and type 2 diabetes in Estonian population.
Douroudis K; Prans E; Haller K; Nemvalts V; Rajasalu T; Tillmann V; Kisand K; Uibo R
Tissue Antigens; 2008 Nov; 72(5):425-30. PubMed ID: 18764813
[TBL] [Abstract][Full Text] [Related]
12. Influence of
Armitage LH; Wallet MA; Mathews CE
Front Immunol; 2021; 12():636618. PubMed ID: 33717184
[TBL] [Abstract][Full Text] [Related]
13. Association between PTPN22 C1858T and type 1 diabetes: a replication in continental Italy.
Saccucci P; Del Duca E; Rapini N; Verrotti A; Piccinini S; Maccari A; Canu G; Angelini F; Fontana L; Giannini C; Chiarelli F; Manca Bitti ML; Bottini N
Tissue Antigens; 2008 Mar; 71(3):234-7. PubMed ID: 18179648
[TBL] [Abstract][Full Text] [Related]
14. Association of PTPN22 C1858T polymorphism and type 1 diabetes: a meta-analysis.
Peng H; Zhou M; Xu WD; Xu K; Zhai Y; Li R; Wang W; Zhang YJ; Liu SS; Pan HF; Ye DQ
Immunol Invest; 2012; 41(5):484-96. PubMed ID: 22429252
[TBL] [Abstract][Full Text] [Related]
15. The Autoimmune Risk Variant
Metzler G; Dai X; Thouvenel CD; Khim S; Habib T; Buckner JH; Rawlings DJ
J Immunol; 2017 Oct; 199(7):2249-2260. PubMed ID: 28801357
[TBL] [Abstract][Full Text] [Related]
16. UBASH3A Interacts with PTPN22 to Regulate
Newman JRB; Concannon P; Ge Y
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240014
[TBL] [Abstract][Full Text] [Related]
17. PTPN22 Single-Nucleotide Polymorphisms in Iranian Patients with Type 1 Diabetes Mellitus.
Abbasi F; Soltani S; Saghazadeh A; Soltaninejad E; Rezaei A; Zare Bidoki A; Bahrami T; Amirzargar AA; Rezaei N
Immunol Invest; 2017 May; 46(4):409-418. PubMed ID: 28375784
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population.
Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
BMC Med Genet; 2007 Aug; 8():54. PubMed ID: 17697317
[TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetes mellitus. Comparison between the association with PTPN22 genotype and the association with ACP1-ADA1 joint genotype.
Gloria-Bottini F; Saccucci P; Manca-Bitti ML; Rapini N; Verrotti A; Neri A; Magrini A; Bottini E
Diabetes Res Clin Pract; 2014 Oct; 106(1):e7-9. PubMed ID: 25125338
[TBL] [Abstract][Full Text] [Related]
20. Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes.
Lempainen J; Vaarala O; Mäkelä M; Veijola R; Simell O; Knip M; Hermann R; Ilonen J
J Autoimmun; 2009 Sep; 33(2):155-64. PubMed ID: 19473815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
